Sarcopenia as a Risk Factor in Patients Undergoing Transjugular Intrahepatic Portosystemic Shunt (TIPS) Implantation
Abstract
:1. Introduction
2. Materials and Methods
3. Results
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
Abbreviations
AI | Artificial intelligence |
ATR | Adipose tissue ratio |
BMI | Body Mass Index |
CI | Confidence interval |
CT | Computed tomography |
DICOM | Digital Imaging and Communications in Medicine |
HE | Hepatic encephalopathy |
HR | Hazard ratio |
LSMI | Lumbar skeletal muscle index |
PACS | Picture archiving and communication system |
PMA | Psoas muscle area |
PPG | Portal Pressure Gradient |
SAT | Subcutaneous adipose tissue |
SF | Subcutaneous Fat Area |
SFT | Subcutaneous Fat Thickness |
SMA | Skeletal muscle area |
SMI | Skeletal muscle index |
TAMA | Total abdominal muscle area |
TIPS | Transjugular intrahepatic portosystemic shunt |
VAT | Visceral adipose tissue |
References
- Rössle, M.; Richter, G.M.; Noeldge, G.; Siegerstetter, V.; Palmaz, J.C.; Wenz, W.; Gerok, W. The intrahepatic portosystemic shunt. Initial clinical experiences with patients with liver cirrhosis. Dtsch. Med. Wochenschr. 1989, 114, 1511–1516. [Google Scholar] [CrossRef] [PubMed]
- Schultheiß, M.; Bettinger, D.; Thimme, R.; Rössle, M. 30 Years of Transjugular Intrahepatic Portosystemic Shunt (TIPS): Casting a retrospective glance and future perspectives. Z. Gastroenterol. 2020, 58, 877–889. [Google Scholar] [CrossRef] [PubMed]
- Tsien, C.; Shah, S.N.; McCullough, A.J.; Dasarathy, S. Reversal of sarcopenia predicts survival after a transjugular intrahepatic portosystemic stent. Eur. J. Gastroenterol. Hepatol. 2013, 25, 85–93. [Google Scholar] [CrossRef] [PubMed]
- Ronald, J.; Bozdogan, E.; Zaki, I.H.; Kappus, M.R.; Choi, S.S.; Martin, J.G.; Suhocki, P.V.; Smith, T.P.; Kim, C.Y.; Bashir, M.R. Relative Sarcopenia With Excess Adiposity Predicts Survival After Transjugular Intrahepatic Portosystemic Shunt Creation. Am. J. Roentgenol. 2019, 214, 200–205. [Google Scholar] [CrossRef]
- Liu, J.; Ma, J.; Yang, C.; Chen, M.; Shi, Q.; Zhou, C.; Huang, S.; Chen, Y.; Wang, Y.; Li, T.; et al. Sarcopenia in Patients with Cirrhosis after Transjugular Intrahepatic Portosystemic Shunt Placement. Radiology 2022, 303, 711–719. [Google Scholar] [CrossRef]
- Nardelli, S.; Bellafante, D.; Ridola, L.; Faccioli, J.; Riggio, O.; Gioia, S. Prevention of post-tips hepatic encephalopathy: The search of the ideal candidate. Metab. Brain. Dis. 2023, 38, 1729–1736. [Google Scholar] [CrossRef]
- Periyalwar, P.; Dasarathy, S. Malnutrition in cirrhosis: Contribution and consequences of sarcopenia on metabolic and clinical responses. Clin. Liver Dis. 2012, 16, 95–131. [Google Scholar] [CrossRef]
- Norman, K.; Kirchner, H.; Lochs, H.; Pirlich, M. Malnutrition affects quality of life in gastroenterology patients. World J. Gastroenterol. 2006, 12, 3380–3385. [Google Scholar] [CrossRef]
- Fehrenbach, U.; Wuensch, T.; Gabriel, P.; Segger, L.; Yamaguchi, T.; Auer, T.A.; Beetz, N.L.; Denecke, C.; Kröll, D.; Raakow, J.; et al. CT Body Composition of Sarcopenia and Sarcopenic Obesity: Predictors of Postoperative Complications and Survival in Patients with Locally Advanced Esophageal Adenocarcinoma. Cancers 2021, 13, 2921. [Google Scholar] [CrossRef]
- Beetz, N.L.; Geisel, D.; Maier, C.; Auer, T.A.; Shnayien, S.; Malinka, T.; Neumann, C.C.M.; Pelzer, U.; Fehrenbach, U. Influence of Baseline CT Body Composition Parameters on Survival in Patients with Pancreatic Adenocarcinoma. J. Clin. Med. 2022, 11, 2356. [Google Scholar] [CrossRef]
- Dahlmann, S.; Bressem, K.; Bashian, B.; Ulas, S.T.; Rattunde, M.; Busch, F.; Makowski, M.R.; Ziegeler, K.; Adams, L. Sex Differences in Renal Cell Carcinoma: The Importance of Body Composition. Ann. Surg. Oncol. 2023, 30, 1269–1276. [Google Scholar] [CrossRef] [PubMed]
- Beetz, N.L.; Geisel, D.; Shnayien, S.; Auer, T.A.; Globke, B.; Öllinger, R.; Trippel, T.D.; Schachtner, T.; Fehrenbach, U. Effects of Artificial Intelligence-Derived Body Composition on Kidney Graft and Patient Survival in the Eurotransplant Senior Program. Biomedicines 2022, 10, 554. [Google Scholar] [CrossRef] [PubMed]
- Beetz, N.L.; Maier, C.; Shnayien, S.; Trippel, T.D.; Gehle, P.; Fehrenbach, U.; Geisel, D. Artificial intelligence-based analysis of body composition in Marfan: Skeletal muscle density and psoas muscle index predict aortic enlargement. J. Cachexia Sarcopenia Muscle 2021, 12, 993–999. [Google Scholar] [CrossRef] [PubMed]
- Miljkovic, I.; Vella, C.A.; Allison, M. Computed Tomography-Derived Myosteatosis and Metabolic Disorders. Diabetes Metab. J. 2021, 45, 482–491. [Google Scholar] [CrossRef] [PubMed]
- Cruz-Jentoft, A.J.; Bahat, G.; Bauer, J.; Boirie, Y.; Bruyère, O.; Cederholm, T.; Cooper, C.; Landi, F.; Rolland, Y.; Sayer, A.A.; et al. Sarcopenia: Revised European consensus on definition and diagnosis. Age Ageing 2019, 48, 16–31. [Google Scholar] [CrossRef]
- EASL Clinical Practice Guidelines on nutrition in chronic liver disease. J. Hepatol. 2019, 70, 172–193. [CrossRef]
- Büttner, L.; Aigner, A.; Pick, L.; Brittinger, J.; Steib, C.J.; Böning, G.; Streitparth, F. 25 years of experience with transjugular intrahepatic portosystemic shunt (TIPS): Changes in patient selection and procedural aspects. Insights Imaging 2022, 13, 73. [Google Scholar] [CrossRef]
- Su, H.; Ruan, J.; Chen, T.; Lin, E.; Shi, L. CT-assessed sarcopenia is a predictive factor for both long-term and short-term outcomes in gastrointestinal oncology patients: A systematic review and meta-analysis. Cancer Imaging 2019, 19, 82. [Google Scholar] [CrossRef]
- Prado, C.M.; Lieffers, J.R.; McCargar, L.J.; Reiman, T.; Sawyer, M.B.; Martin, L.; Baracos, V.E. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: A population-based study. Lancet Oncol. 2008, 9, 629–635. [Google Scholar] [CrossRef]
- Therneau, T.M.; Grambsch, P.M. (Eds.) The Cox Model. In Modeling Survival Data: Extending the Cox Model; Springer New York: New York, NY, USA, 2000; pp. 39–77. [Google Scholar]
- Therneau, T. A Package for Survival Analysis in R, R package version 3.5-0; Springer: New York, NY, USA, 2023.
- Wickham, H.; Averick, M.; Bryan, J.; Chang, W.; McGowan, L.D.A.; François, R.; Grolemund, G.; Hayes, A.; Henry, L.; Hester, J. Welcome to the Tidyverse. J. Open Source Softw. 2019, 4, 1686. [Google Scholar] [CrossRef]
- R-Core-Team. R: A Language and Environment for Statistical Computing; R Foundation for Statistical Computing: Vienna, Austria, 2023. [Google Scholar]
- Plauth, M.; Schütz, T.; Buckendahl, D.P.; Kreymann, G.; Pirlich, M.; Grüngreiff, S.; Romaniuk, P.; Ertl, S.; Weiss, M.L.; Lochs, H. Weight gain after transjugular intrahepatic portosystemic shunt is associated with improvement in body composition in malnourished patients with cirrhosis and hypermetabolism. J. Hepatol. 2004, 40, 228–233. [Google Scholar] [CrossRef] [PubMed]
- Pang, N.; Zhao, C.; Li, J.; Li, L.; Yang, X.; Yang, M.; Wu, Z.; Feng, D. Body mass index changes after transjugular intrahepatic portosystemic shunt in individuals with cirrhosis. Nutrition 2021, 84, 111095. [Google Scholar] [CrossRef] [PubMed]
- Cheung, K.; Lee, S.S.; Raman, M. Prevalence and mechanisms of malnutrition in patients with advanced liver disease, and nutrition management strategies. Clin. Gastroenterol. Hepatol. 2012, 10, 117–125. [Google Scholar] [CrossRef] [PubMed]
- Allard, J.P.; Chau, J.; Sandokji, K.; Blendis, L.M.; Wong, F. Effects of ascites resolution after successful TIPS on nutrition in cirrhotic patients with refractory ascites. Am. J. Gastroenterol. 2001, 96, 2442–2447. [Google Scholar] [CrossRef]
- Montano-Loza, A.J.; Meza-Junco, J.; Prado, C.M.; Lieffers, J.R.; Baracos, V.E.; Bain, V.G.; Sawyer, M.B. Muscle wasting is associated with mortality in patients with cirrhosis. Clin. Gastroenterol. Hepatol. 2012, 10, 166–173.e1. [Google Scholar] [CrossRef]
- Ebadi, M.; Bhanji, R.A.; Tandon, P.; Mazurak, V.; Baracos, V.E.; Montano-Loza, A.J. Review article: Prognostic significance of body composition abnormalities in patients with cirrhosis. Aliment. Pharmacol. Ther. 2020, 52, 600–618. [Google Scholar] [CrossRef]
- Praktiknjo, M.; Book, M.; Luetkens, J.; Pohlmann, A.; Meyer, C.; Thomas, D.; Jansen, C.; Feist, A.; Chang, J.; Grimm, J.; et al. Fat-free muscle mass in magnetic resonance imaging predicts acute-on-chronic liver failure and survival in decompensated cirrhosis. Hepatology 2018, 67, 1014–1026. [Google Scholar] [CrossRef]
- Kang, S.H.; Jeong, W.K.; Baik, S.K.; Cha, S.H.; Kim, M.Y. Impact of sarcopenia on prognostic value of cirrhosis: Going beyond the hepatic venous pressure gradient and MELD score. J. Cachexia Sarcopenia Muscle 2018, 9, 860–870. [Google Scholar] [CrossRef]
- Benmassaoud, A.; Roccarina, D.; Arico, F.; Leandro, G.; Yu, B.; Cheng, F.; Yu, D.; Patch, D.; Tsochatzis, E. Sarcopenia Does Not Worsen Survival in Patients With Cirrhosis Undergoing Transjugular Intrahepatic Portosystemic Shunt for Refractory Ascites. Am. J. Gastroenterol. 2020, 115, 1911–1914. [Google Scholar] [CrossRef]
- Praktiknjo, M.; Clees, C.; Pigliacelli, A.; Fischer, S.; Jansen, C.; Lehmann, J.; Pohlmann, A.; Lattanzi, B.; Krabbe, V.K.; Strassburg, C.P.; et al. Sarcopenia Is Associated With Development of Acute-on-Chronic Liver Failure in Decompensated Liver Cirrhosis Receiving Transjugular Intrahepatic Portosystemic Shunt. Clin. Transl. Gastroenterol. 2019, 10, e00025. [Google Scholar] [CrossRef]
- Baumann, B.C.; Wei, J.; Plastaras, J.P.; Lukens, J.N.; Damjanov, N.; Hoteit, M.; Hsu, C.; Levine, M.; Mondschein, J.; Nadolski, G.; et al. Stereotactic Body Radiation Therapy (SBRT) for Hepatocellular Carcinoma: High Rates of Local Control With Low Toxicity. Am. J. Clin. Oncol. 2018, 41, 1118–1124. [Google Scholar] [CrossRef] [PubMed]
- Merli, M.; Giusto, M.; Lucidi, C.; Giannelli, V.; Pentassuglio, I.; Di Gregorio, V.; Lattanzi, B.; Riggio, O. Muscle depletion increases the risk of overt and minimal hepatic encephalopathy: Results of a prospective study. Metab. Brain Dis. 2013, 28, 281–284. [Google Scholar] [CrossRef] [PubMed]
- Nardelli, S.; Lattanzi, B.; Torrisi, S.; Greco, F.; Farcomeni, A.; Gioia, S.; Merli, M.; Riggio, O. Sarcopenia Is Risk Factor for Development of Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt Placement. Clin. Gastroenterol. Hepatol. 2017, 15, 934–936. [Google Scholar] [CrossRef] [PubMed]
- Bhanji, R.A.; Moctezuma-Velazquez, C.; Duarte-Rojo, A.; Ebadi, M.; Ghosh, S.; Rose, C.; Montano-Loza, A.J. Myosteatosis and sarcopenia are associated with hepatic encephalopathy in patients with cirrhosis. Hepatol. Int. 2018, 12, 377–386. [Google Scholar] [CrossRef]
- Gioia, S.; Merli, M.; Nardelli, S.; Lattanzi, B.; Pitocchi, F.; Ridola, L.; Riggio, O. The modification of quantity and quality of muscle mass improves the cognitive impairment after TIPS. Liver Int. 2019, 39, 871–877. [Google Scholar] [CrossRef]
No Sarcopenia (n = 60) | Sarcopenia (n = 135) | Total (n = 195) | |
---|---|---|---|
BMI (Median (IQR)) | 29.05 (26.1, 33.1) | 24.86 (21.9, 28.6) | 26.26 (23.03, 30.0) |
TAMA (Median (IQR)) | 158.5 (121.7, 179.8) | 113.1(89.1, 137.3) | 124.5 (97.2, 147.7) |
VAT (Median (IQR)) | 127.9 (70.6, 196.4) | 62.5 (31.5, 121.4) | 77.4 (41.5, 150.9) |
SMA (Median (IQR)) | 142.3 (110.5, 160.2) | 100.0 (82.4, 122.1) | 111.3 (88.4, 131.5) |
ATR (Median (IQR)) | 0.6 (0.4, 0.9) | 0.7 (0.4, 1.1) | 0.7 (0.4, 1.0) |
LSMI (Median (IQR)) | 54.0 (45.0, 60.1) | 37.4 (31.6, 43.7) | 41.8 (33.9, 49.7) |
PMA (Median (IQR)) | 14.7 (11.1, 20.0) | 11.2 (7.8, 14.9) | 12.2 (8.6, 15.8) |
SAT (Median (IQR)) | 211.4 (147.1, 289.3) | 90.1 (54.4, 164.9) | 132.8 (63.1, 212.6) |
Outcome Parameters | Sarcopenia (n = 135) | No Sarcopenia (n = 60) | Sarcopenic Obesity (n = 22) | No Sarcopenic Obesity (n = 171) | LSMI [cm2/m2] 41.8 (33.9, 49.7) | |
---|---|---|---|---|---|---|
HE | Yes | 36 (26.7%) | 10 (16.7% | 7 (31.8%) | 38 (22.2%) | 41.70 (34.48, 48.26) |
No | 99 (73.3%) | 50 (83.3%) | 15 (68.2%) | 133 (77.8%) | 42.03 (33.85, 49.83) | |
Complication | Yes | 60 (44.4%) | 17 (28.3%) | 8 (36.4%) | 67 (39.2%) | 40.61 (31.62, 49.59) |
No | 75 (55.6%) | 43 (71.7%) | 14 (63.6%) | 104 (60.8%) | 42.56 (36.23, 49.78) | |
TIPS dysfunction | Yes | 28 (20.7%) | 16 (26.7%) | 9 (40.9%) | 34 (19.9%) | 42.49 (33.74, 52.50) |
No | 107 (79.3%) | 44 (73.3%) | 13 (59.1%) | 137 (80.1%) | 41.59 (34.23, 48.26) | |
Death | Yes | 34 (25.2%) | 13 (21.7%) | 3 (13.6%) | 44 (25.7%) | 42.64 (36.90, 50.16) |
No | 101 (74.8%) | 47 (78.3%) | 19 (86.4%) | 127 (74.3%) | 41.51 (33.69, 49.62) |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Büttner, L.; Aigner, A.; Stegherr, R.; Iseke, S.; Jonczyk, M.; Lüdemann, W.M.; Auer, T.A.; Collettini, F.; Schnapauff, D.; de Bucourt, M.; et al. Sarcopenia as a Risk Factor in Patients Undergoing Transjugular Intrahepatic Portosystemic Shunt (TIPS) Implantation. Diagnostics 2025, 15, 1440. https://doi.org/10.3390/diagnostics15111440
Büttner L, Aigner A, Stegherr R, Iseke S, Jonczyk M, Lüdemann WM, Auer TA, Collettini F, Schnapauff D, de Bucourt M, et al. Sarcopenia as a Risk Factor in Patients Undergoing Transjugular Intrahepatic Portosystemic Shunt (TIPS) Implantation. Diagnostics. 2025; 15(11):1440. https://doi.org/10.3390/diagnostics15111440
Chicago/Turabian StyleBüttner, Laura, Annette Aigner, Regina Stegherr, Simon Iseke, Martin Jonczyk, Willie Magnus Lüdemann, Timo Alexander Auer, Federico Collettini, Dirk Schnapauff, Maximilian de Bucourt, and et al. 2025. "Sarcopenia as a Risk Factor in Patients Undergoing Transjugular Intrahepatic Portosystemic Shunt (TIPS) Implantation" Diagnostics 15, no. 11: 1440. https://doi.org/10.3390/diagnostics15111440
APA StyleBüttner, L., Aigner, A., Stegherr, R., Iseke, S., Jonczyk, M., Lüdemann, W. M., Auer, T. A., Collettini, F., Schnapauff, D., de Bucourt, M., Gebauer, B., Geisel, D., & Böning, G. (2025). Sarcopenia as a Risk Factor in Patients Undergoing Transjugular Intrahepatic Portosystemic Shunt (TIPS) Implantation. Diagnostics, 15(11), 1440. https://doi.org/10.3390/diagnostics15111440